Publication | Closed Access

Orally active desulfated low molecular weight heparin and deoxycholic acid conjugate, 6ODS-LHbD, suppresses neovascularization and bone destruction in arthritis

InflammationRheumatologyRheumatoid DisorderSclerostinAnti-inflammatoryMusculoskeletal ResearchBiochemistryMedicineOsteoarthritisDeoxycholic Acid ConjugateInflammatory Rheumatic DiseaseBone DestructionPharmacologyOsteoporosisInflammatory ArthritisRheumatoid ArthritisOxidative Stress